Sara Nik News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Lisata Therapeutics, Inc (NASDAQ:LSTA) Q1 2024 Earnings Call Transcript

Lisata Therapeutics, Inc (NASDAQ:LSTA) Q1 2024 Earnings Call Transcript
insidermonkey.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from insidermonkey.com Daily Mail and Mail on Sunday newspapers.

United statesNew south walesNew zealandJohn mendittoRobert leboyerPete enderlinErkki ruoslahtiDavid mazzoJames niscoRobert sassoonJoseph pantginisSteve brozakSara nikTherapeutic goods administrationClinical trial centerTherapeutic goods regulatory agency of the australian

Oncology Co Receives Buy Rating for New Drug Trials

Oncology Co. Receives Buy Rating for New Drug Trials

United statesSara nikMatthew kellerJoseph pantginisCori rupeHc wainwright coDeposit insurance corporationStreetwise reportsAmerican centerCancer researchKura oncology incH cwainwright coHc wainwright coSyndax pharmaceuticals incKura oncologyStreetwise report

Phase 2b Trial of New Drug for Ovarian Cancer Starts

Phase 2b Trial of New Drug for Ovarian Cancer Starts

United statesUnited kingdomSara nikMatthew kellerJoseph pantginisGynecologic oncology group foundationDeposit insurance corporationEuropean network of gynaecological oncological trialEuropean unionHc wainwright coHc wainwright coNuvectis pharma incStreetwise reportsNuvectis pharmaGynecologic oncology groupEuropean network

aTyr Pharma, Inc (NASDAQ:LIFE) Q4 2022 Earnings Call Transcript

Operator: Good afternoon, ladies and gentlemen, and welcome to the aTyr Pharma Fourth Quarter and Full Year 2022 Conference Call. At this time, all participants are in a listen-only mode.

Joseph pantginisJill broadfootYale jenSanjay shuklaGregory renzaAshlee dunstonGeorge renzaSara nikAtyr pharma incLife technologies corpCorporate communicationsTyr pharmaCall transcript marchTyr pharma fourth quarterFull yearInvestor relations